ÂÜÀòÂÒÂ×

Neil Minton is a seasoned expert in pharmacovigilance with extensive experience in senior leadership roles across the pharmaceutical industry. Currently serving as Senior Vice President of Pharmacovigilance at Mirum Pharmaceuticals, Inc., Neil previously held similar positions at Ambrx and Bristol Myers Squibb, where responsibilities included overseeing patient safety in therapeutic areas such as cardiovascular, fibrosis, and neuroscience. Neil's career also includes significant contributions at Celgene, Shire Pharmaceuticals, Johnson & Johnson, Zeneca, and Glaxo. Educational qualifications encompass an MD in Clinical Pharmacology and Toxicology, an MB ChB in Medicine, and a BSc in Physiology from the University of Birmingham, alongside advanced certifications from the Royal College of Physicians, UK.